ACM
BMY icon

Aljian Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Aljian Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
17,481
+473
+3% +$27.6K 0.22% 57
2025
Q4 		$917K Sell
17,008
-1,293
-7% -$62.2K 0.18% 58
2025
Q3 		$825K Sell
18,301
-830
-4% -$38.8K 0.17% 65
2025
Q2 		$886K Sell
19,131
-1,735
-8% -$85.2K 0.19% 62
2025
Q1 		$1.27M Buy
20,866
+4,745
+29% +$277K 0.3% 42
2024
Q4 		$912K Buy
16,121
+1,041
+7% +$58.2K 0.2% 53
2024
Q3 		$780K Buy
+15,080
New +$707K 0.18% 59

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aljian Capital Management's BMY Position: Q1 2026 in Review

Aljian Capital Management increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, buying an estimated $27.6K and bringing the position to 17,481 shares worth $1.06M. The position accounts for 0.22% of the portfolio, ranked #57.

Aljian Capital Management first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.27M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Aljian Capital Management held 17,481 shares of Bristol-Myers Squibb worth $1.06M as of Q1 2026.
  • Aljian Capital Management bought 473 Bristol-Myers Squibb shares in Q1 2026, an estimated $27.6K.
  • Bristol-Myers Squibb made up 0.22% of Aljian Capital Management's portfolio in Q1 2026, its #57 holding.
  • Aljian Capital Management first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • Aljian Capital Management's Bristol-Myers Squibb position peaked at $1.27M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Aljian Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.